GENEX - Crunchbase Company Profile & Funding

Q: Where is GENEX's headquarters?

GENEX is located in Tokyo, Tokyo, Japan.

Q: Who invested in GENEX?

GENEX has 3 investors including Kaken Pharmaceutical And Monex Group.

Q: When was the last funding round for GENEX?

GENEX closed its last funding round on obfuscated from a Seed round.

Overview

GENEX

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About GENEX

CB Rank

989850

GENEX advances rare disease research and management, offering whole-genome testing and collaborative medical solutions.

Founded

obfuscation

Private

Seed

Tokyo, Tokyo, Japan

11-50

genex.co.jp/

Health Care

Medical

Pharmaceutical

Funding Rounds

Seed

OBF

obfuscation

Key People

Kohei Matsumaru: Representative Director and Founder

Details

Legal Name

GENEX, Inc.

Also Known As

ジーネックス

Operating Status

Active

Company Type

For Profit

Founders

Kohei Matsumaru

About the Company

GENEX is a genome molecular testing service. They provide drug discovery and development pipelines to the greater pharma community and supporting organizations. They offer services like documentation, ethics procedures, outreach to patients, electronic informed consent, sample collection, genomic analysis, and data storage and management. They

store genomic information in secure cloud storage. They support diagnoses and clinical trials for mitochondrial disease.

Phone Number

+82 31-721-5909

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Whole Genome Testing Service (Standard)

A service that performs whole genome sequencing using short-read technology to identify genetic variants across approximately 20,000 genes for medical institutions and research organizations.

Exome Testing Service (Entry)

A service that sequences only the exome regions of the genome to detect genetic variants, targeting medical and research institutions.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - GENEX	3	obfuscated obfuscation	—	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Kaken Pharmaceutical	—	Seed Round - GENEX	—
Kaken Pharmaceutical	—	Seed Round - GENEX	—
Kaken Pharmaceutical	—	Seed Round - GENEX	—
Kaken Pharmaceutical	—	Seed Round - GENEX	—
Kaken Pharmaceutical	—	Seed Round - GENEX	—